Breakthrough Technology
Transcranial magnetic stimulation or TMS is cleared by the FDA in 2008 for treatment of depression and OCD as well as in Europe for additional indications. Hundreds of clinical trials have been conducted with TMS and repetitive TMS, showing it to be safe and well-tolerated.
Applied to the eye, repetitive magnetic stimulation (RMS) works by activating multiple nerves around the eye.
Aqueous tear flow is modulated by the nasolacrimal reflex. The signal passes through the ophthalmic and maxillary nerves to the trigeminal nerve then synapse in the brain stem. From the brain stem, impulses are generated downstream to control the lacrimal function nerve through sympathetic and parasympathetic nerves.
The Epitech device applies RMS to the eye area. A magnetically-induced electric field activates multiple branches of the trigeminal nerve simultaneously, a single treatment resulting in delayed long-lasting effects.
Pflugfelder, Beuerman, Stern. Dry Eye and Ocular Surface Disorders. Taylor & Francis Group, 2004
The Solution
Epitech has developed a device which addresses the root cause of dry eye.
The Epitech device uses repetitive magnetic stimulation (RMS) on the cornea to protect corneal epithelium cells from drying out.